Form 4 for HBIO HARVARD BIOSCIENCE INC
Accepted 2022-08-22 00:00:00 ET · period of report 2022-08-18 · accession 0000921895-22-002509 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-08-22 | 2022-08-18+ | HBIO | LOY BERTRAND | Dir | P - Purchase | $3.27 | +10.8K | 351.0K | +3% | +$35.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-18 | P | A | 1,151 | $3.19 | 341,360 | D | — | — | (F1) This transaction was executed in multiple trades at prices ranging from $3.175 to $3.20, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. (F2) Includes (a) the shares purchased in the transaction described in footnote (1) above, (b) 47,493 restricted stock units that will vest on the earlier to occur of (i) the date of the Issuer's next Annual Meeting of Stockholders, immediately prior to the commencement of such meeting, and (ii) May 24, 2023, and (c) 292,716 shares of common stock held by the Reporting Person. |
| 2 | Common | Common Stock | 2022-08-19 | P | A | 9,608 | $3.28 | 350,968 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $3.24 to $3.30, inclusive. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. (F4) Includes (a) the shares described in footnote (2) above and (b) the shares purchased in the transaction described in footnote (3) above. |